In a randomized, double-blind, placebo-controlled crossover trial of 30 adults with obesity (Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity, Blundell and colleagues, Diabetes, Obesity and Metabolism , 2017), 12 weeks of once-weekly semaglutide titrated to 1.0 mg was associated with less hunger, fewer food cravings, better control of eating, and a lower preference for high-fat foods
Disclaimer: Compounded medications are not FDA-approved, but are prepared under federal and state compounding guidelines to meet safety standards
Your doctor could attribute these changes to diet modifications, exercise, a new supplement, or pharmacological intervention
One girl just kept looking at her phone